BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 19
• 20
• 21
• 22
• 23
• 24
• 26
• 27
• 28
• 29
• 30

• Business

  ThromboGenics Strengthens Leadership Team - Susan Schneider, MD Appointed Chief Medical Officer and Vinciane Vangeersdaele Appointed Chief Commercial Officer

  Both will be members of the Company’s executive team reporting to ThromboGenics’ CEO, and they will operate from the Company’s offices in Leuven, Belgium and Iselin, New Jersey, US.

  November 8, 2017

   · 

  4 min read
• Genetown

  Voyager Therapeutics Announces Pricing of Public Offering of Common Stock

  Voyager has granted the underwriters a 30-day option to purchase up to an additional 675,000 shares of common stock at the public offering price.

  November 8, 2017

   · 

  4 min read
• Business

  Aeglea BioTherapeutics Provides Corporate Update and Reports Third Quarter 2017 Financial Results

  On September 30, 2017, Aeglea had available cash, cash equivalents and marketable securities of $55.7 million.

  November 8, 2017

   · 

  7 min read
• Drug Development

  Nymox Reports on Symposium, Panel Discussion and Podium Presentation on Fexapotide at American Urological Association New York Section Annual Meeting in Havana

  The Podium presentation was given by Dr. Ivan Grunberger MD FACS, Professor of Clinical Urology, Weill Cornell Medical College and Chief of Urology, NYP Brooklyn Methodist Hospital.

  November 8, 2017

   · 

  4 min read
• Business

  Moleculin Appoints Dr. Sandra Silberman as CMO - New Products

  Moleculin Biotech announced the appointment of Dr. Sandra Silberman as CMO in charge of New Products.

  November 8, 2017

   · 

  4 min read
• Business

  Vermillion Reports Third Quarter 2017 Results

  Conference call is scheduled for 4:30 p.m. ET today.

  November 8, 2017

   · 

  18 min read
• Business

  Natera Reports Third Quarter 2017 Financial Results

  Generated total revenues of $56.7 million in the third quarter of 2017 compared to $53.9 million in the third quarter of 2016.

  November 8, 2017

   · 

  22 min read
• Business

  Alexion Appoints Francois Nader, M.D. to Its Board of Directors

  Dr. Nader is an accomplished leader in the biopharmaceutical industry with a proven track record of building and transforming companies, launching rare disease therapies, and creating significant shareholder value.

  November 8, 2017

   · 

  4 min read
• Genetown

  Akebia Therapeutics Announces Third Quarter 2017 Financial Results

  Akebia reported a net loss of ($23.1) million, or ($0.49) per share, for the third quarter of 2017 as compared to a net loss for the third quarter of 2016 of ($36.3) million or ($0.96) per share.

  November 8, 2017

   · 

  7 min read
• Business

  Invitae Corporation Issues Reminder Regarding Exchange Offer for CombiMatrix Corporation Series F Warrants

  Exchange offer to expire one minute after 11:59 p.m., New York City time, on November 13, 2017, unless extended.

  November 8, 2017

   · 

  10 min read